Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A lung carcinoma characterized by a combination of small cell carcinoma and squamous cell carcinoma.
Biomarker and diagnostic research for lung mixed small cell and squamous cell carcinoma has been reported in the published literature.
No clinical trials have been registered for lung mixed small cell and squamous cell carcinoma.
207 publications have been identified in PubMed for lung mixed small cell and squamous cell carcinoma. Kisho has analyzed 146 by research type. Research spans Basic Science / Preclinical (29%), Review / Meta-Analysis (17%), and Clinical Trial Publication (16%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 43 | 29% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 6:56 PM UTC
Research summaries |
25 |
17% |
Clinical study results | 24 | 16% |
New treatment approaches | 22 | 15% |
Testing and diagnosis research | 16 | 11% |
Disease patterns and progression | 12 | 8% |
Patient case studies | 4 | 3% |
Hao Y (2026). [PMID: 41689318](https://pubmed.ncbi.nlm.nih.gov/41689318/). *J Coll Physicians Surg Pak*. [Epidemiology / Natural History]
Yang Y (2026). [PMID: 41554474](https://pubmed.ncbi.nlm.nih.gov/41554474/). *Cancer Lett*. [Basic Science / Preclinical]
Bradová M (2026). [PMID: 41986521](https://pubmed.ncbi.nlm.nih.gov/41986521/). *Virchows Arch*. [Epidemiology / Natural History]
Cavazzoni A (2026). [PMID: 41581311](https://pubmed.ncbi.nlm.nih.gov/41581311/). *Lung Cancer*. [Basic Science / Preclinical]
Gandara DR (2026). [PMID: 41808570](https://pubmed.ncbi.nlm.nih.gov/41808570/). *Cancer*. [Review / Meta-Analysis]
Paik PK (2026). [PMID: 41253679](https://pubmed.ncbi.nlm.nih.gov/41253679/). *Clin Lung Cancer*. [Review / Meta-Analysis]
Haghighi H (2026). [PMID: 41961052](https://pubmed.ncbi.nlm.nih.gov/41961052/). *J Mater Chem B*. [Basic Science / Preclinical]
Hong Q (2026). [PMID: 41495391](https://pubmed.ncbi.nlm.nih.gov/41495391/). *Clin Drug Investig*. [Clinical Trial Publication]
Sumii M (2026). [PMID: 41194504](https://pubmed.ncbi.nlm.nih.gov/41194504/). *Mol Cancer Ther*. [Gene Therapy / Novel Therapeutics]
Wang Z (2026). [PMID: 41159493](https://pubmed.ncbi.nlm.nih.gov/41159493/). *Adv Sci (Weinh)*. [Clinical Trial Publication]